About Wave Pharmaceuticals Limited
Data last updated:
Wave Pharmaceuticals Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PLC088998. Its GSTIN is 07AAACW2771M2ZY (Delhi). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.95 Cr. It is led by directors including Nikhil Gupta and Sanjay Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 6 Oberoi Appartments, 2 Sham Nath Marg Civil Lines, Delhi, India – 110054.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.93 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹8.58 Lakh (net margin 4.4%) and EBITDA of -₹54.4 Lakh (EBITDA margin -28.2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 267% over five years.
The company is associated with 1 brand: Wave Pharmaceuticals Limited. As per MCA filings, the company has satisfied charges of ₹50.65 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wavepharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 6 Oberoi Appartments, 2 Sham Nath Marg Civil Lines, Delhi, India – 110054
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Wave Pharmaceuticals Limited
Wave Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231DL1997PLC088998. The current CIN is U24231DL1997PLC088998, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231DL1997PLC088998 | Current |
| L24231DL1997PLC088998 | Previous |
Associated Brands with Wave Pharmaceuticals Limited
Wave Pharmaceuticals operates one associated brand: Wave Pharmaceuticals Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development and manufacturing of pharmaceutical products globally by Wave Pharmaceuticals Limited. | wavepharma.in |
Auditor Details of Wave Pharmaceuticals Limited
Wave Pharmaceuticals Limited is audited by KSMC & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KSMC & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wave Pharmaceuticals Limited
Wave Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Gupta Also directs: Iwave Pharmaceuticals Private Limited | Director | 28 Jan 2017 | 9 Years 8 Months | Current |
| Sanjay Gupta Also directs: Iwave Pharmaceuticals Private Limited | Director | 28 Jan 2017 | 9 Years 8 Months | Current |
| Sarita Gupta | Director | 10 Feb 2018 | 8 Years 7 Months | Current |
Financials of Wave Pharmaceuticals Limited FY 2025 filings available
Wave Pharmaceuticals Limited reported revenue of ₹1.93 Cr (up 50% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Wave Pharmaceuticals Limited
Revenue has grown at a compounded annual rate (CAGR) of 267% over five years, including 50% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wave Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹1.93 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹54.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.58 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wave Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wave Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Wave Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wave Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2003 | Canara Bank | ₹25 Lakh | Satisfied |
| 12 Dec 2001 | Punjab National Bank | ₹25.65 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Wave Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Wave Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Wave Pharmaceuticals Limited
Wave Pharmaceuticals has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW2771M2ZY | Delhi | Active | 03 May 2018 |
| 24AAACW2771M1Z3 | Gujarat | Active | 25 Apr 2019 |
| 05AAACW2771M1Z3 | Uttarakhand | Active | 07 Sep 2019 |
| 08AAACW2771M1ZX | Rajasthan | Active | 23 Feb 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Wave Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wave Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wave Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wave Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Wave Pharmaceuticals Limited
Frequently Asked Questions about Wave Pharmaceuticals Limited
Wave Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 1997 (29+ years old) and is registered under CIN U24231DL1997PLC088998.
Wave Pharmaceuticals reported revenue of ₹1.93 Cr for FY 2023 (up 50% YoY).
Wave Pharmaceuticals has 3 current directors:
- Nikhil Gupta - Director
- Sanjay Gupta - Director
- Sarita Gupta - Director
Wave Pharmaceuticals reported a net profit of ₹8.58 Lakh (net margin 4.4%) and EBITDA of -₹54.4 Lakh (EBITDA margin -28.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wave Pharmaceuticals is -11% over three years and 267% over five years. In the latest year (FY 2023) revenue rose 50%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wave Pharmaceuticals is 07AAACW2771M2ZY, registered in Delhi. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 24AAACW2771M1Z3 (Gujarat), 05AAACW2771M1Z3 (Uttarakhand), 08AAACW2771M1ZX (Rajasthan).
The CIN (Corporate Identification Number) of Wave Pharmaceuticals is U24231DL1997PLC088998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wave Pharmaceuticals was incorporated on 08 August 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Wave Pharmaceuticals can be reached through the website wavepharma.in. Its registered office is in Delhi, India.